From Approval to Treatment, the History of Ipilimumab

In conjunction with the Food and Drug Administration's impending approval of another drug for melanoma treatment, vemurafenib, we present this look on the late-stage melanoma drug ipilimumab, how it was approved and the response that followed.

In conjunction with the Food and Drug Administration's impending approval of another drug for melanoma treatment, vemurafenib, we present this look on the late-stage melanoma drug ipilimumab, how it was approved and the response that followed.

In conjunction with the Food and Drug Administration's impending approval of another drug for melanoma treatment, vemurafenib, we present this look on the late-stage melanoma drug ipilimumab, how it was approved and the response that followed.